(b)(4).
Unique identifier (udi) #: (b)(4).
Report source, foreign: event occurred in (b)(6).
The device will not be returned to the manufacturer.
Therefore it will not be analyzed.
The review of the device manufacturing quality record indicates that (b)(4) products designation refobacin bone cement r 1x40-3, reference (b)(4), lot number 835bae0303 were manufactured on 16 november 2018.
The device manufacturing quality record indicates that the released product met all requirements to perform as intended.
The reported event was unable to be confirmed as the product was not returned.
The device manufacturing quality record indicates that the released product met all requirements to perform as intended.
According to the available data, the most probable root cause is due to packaging issue (sealing process).
Corrective action has been initiated to address reported issue.
If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
Zimmer biomet will continue to monitor for trends.
|
It has been reported that during the opening of the packaging of the powder, this one torn at the seal level.
It was impossible to take off the pouch in sterile manner.
There was no patient involvement, no adverse events have been reported as resultant of the malfunction.
|